Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for SIGA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 57.17%
March 31, 2026 52.89%
December 31, 2025 21.20%
September 30, 2025 61.75%
June 30, 2025 68.50%
March 31, 2025 97.76%
December 31, 2024 82.65%
September 30, 2024 83.81%
June 30, 2024 43.55%
March 31, 2024 87.32%
December 31, 2023 87.29%
September 30, 2023 90.29%
June 30, 2023 83.42%
March 31, 2023 86.18%
December 31, 2022 92.24%
September 30, 2022 94.53%
June 30, 2022 94.71%
March 31, 2022 55.21%
December 31, 2021 86.76%
September 30, 2021 96.95%
June 30, 2021 88.49%
March 31, 2021 94.79%
December 31, 2020 88.52%
September 30, 2020 87.44%
June 30, 2020 88.11%
Date Value
March 31, 2020 93.29%
December 31, 2019 95.40%
September 30, 2019 90.91%
June 30, 2019 0.00%
March 31, 2019 91.25%
December 31, 2018 93.46%
September 30, 2018 79.79%
June 30, 2018 0.00%
March 31, 2018 0.00%
December 31, 2017 0.00%
September 30, 2017 0.00%
June 30, 2017 0.00%
March 31, 2017 0.00%
December 31, 2016 0.00%
September 30, 2016 0.00%
June 30, 2016 0.00%
March 31, 2016 0.00%
December 31, 2015 0.00%
September 30, 2015 0.00%
June 30, 2015 0.00%
March 31, 2015 0.00%
December 31, 2014 0.00%
September 30, 2014 0.00%
June 30, 2014 0.00%
March 31, 2014 0.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 54.97%
Corcept Therapeutics, Inc. 98.41%
Veru, Inc. --
Johnson & Johnson 68.73%
Eli Lilly & Co. 85.78%

Gross Profit Margin (Quarterly) Related Metrics